Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 734 | Longs Won 388/734 52% | Profit Factor 0.78 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $2,057.62 |
| Average Win $448.21 | Best Trade (Sep 18) $8,618.41 | Sharpe Ratio -186.66 |
| Average Loss -$643.72 | Worst Trade (Oct 16) -$33,073.68 | Z-Score -6.1 (100%) |
| Commissions $0 | Avg. Trade Length 2m 6d | Expectancy -$66.51 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 80 | 72 | 64 | 56 | 48 | 40 | 32 | 24 | 16 | 8 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
VKTX Viking Therapeutics Inc. | 2,022.85 | $84,251.91 | $51,178.23 | - | -$33,073.68 | -39.26% | -7.563% |